Dr. Dream Advanced Facial Treatment Serum
- Manufacturer
- Dr. Dream Inc | New & New Co., Ltd
- Effective date
- 2012-08-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:32:53
Label at a glance#
ProductDr. Dream Advanced Facial Treatment Serum
Active ingredientWITCH HAZEL
Label structure8 sections
Label contents#
Full prescribing information#
witch hazel
INACTIVE INGREDIENT SECTION
bis-PEG-18 methyl ether dimethyl silane, polyglutamic acid, butylene glycol, panthenol, sodium PCA, caprylyl glycol, torreya nucifera extract, cornus kousa extract, rosa multiflora fruit extract, chloranthus glaber extract, musa basjoo extract, musa basjoo extract, rh-oligopeptide-1, acetyl hexapeptide=8, palmitoyl oligopeptice, palmitoyl tetrapeptide-7, polysorbate 80, glycerin, caprylhydroxamic acid, adenosine, ammonium acryloyldimethyltaurate, hydroxyethylcellulose, pentylene glycol, cellulose gum, sodium chondroitin sulfate, lavandula angustifolia oil, cymbopogon schoenanthus oil, abies sibirica oil, citrus auratium dulcis peel oil, amyris balsamifera bark oil, salvia sclarea oil, lecithin, sodium phosphate, sodium hyaluronate, rh-polypeptide-60, rh-polypeptide-9, rh-polypeptide-11, rh-polypeptide-2, rh-polypeptide-1, rh-polypeptide-10, copper tripeptide-1, palmitoyl pentapeptide-4, glycine, glutamine, lysine, leucine, methionine, valine, serine, cysteine, cystine, asparagine, alanine, arginine, ornithine, isoleucine,tyrosine, threonine, tryptophan, phenylalanine, proline, histidine
OTC - PURPOSE SECTION
anti wrinkle
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
after cleaning up your face with clean water and apply proper amount to your face and massage to be well absorbed
there would be better effect if you apply it twice a day in the morning and evening
there would be better effect if you apply it twice a day in the morning and evening
WARNINGS SECTION
When using this product
- keep out of eyes, ears, and mouth. If contact occurs, rinse with plenty of cold water right away and contact a physician. If swallowing, drink plenty of water and contact a physician
- keep out of eyes, ears, and mouth. If contact occurs, rinse with plenty of cold water right away and contact a physician. If swallowing, drink plenty of water and contact a physician
DOSAGE & ADMINISTRATION SECTION
for external use only
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 73df98bc-429f-4587-8299-6ad8d52a4f36 | Product name | 2 | 20250304 |
| 2e254488-9fcb-41b3-a7c3-e2c9a3941b29 | Product name | 1 | 20200603 |
| b4ff0805-126a-406d-9cae-fc34fd8e8889 | Product name | 1 | 20190711 |
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| 64b87b8d-6ae7-cef1-8fd2-34228b0cc1bc | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53077-2001-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c827-f6ea-e053-dbdaa90aa703 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53077-2001-1 | Dr. Dream Advanced Facial Treatment Serum | 50 mL in 1 BOTTLE, GLASS | LIQUID | 50 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53077-2001 | DR. DREAM ADVANCED FACIAL TREATMENT SERUM (WITCH HAZEL) LIQUID [DR. DREAM INC] | 1 | Legacy NDC, 1 package rows | 20120829_ce0939de-1b69-4a4f-9641-e10794d9f17c.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| WITCH HAZEL | ACTIVE INGREDIENT | 101I4J0U34 | 1 | |
| WITCH HAZEL | ACTIVE MOIETY | 101I4J0U34 | 1 | |
| ABIES SIBIRICA LEAF OIL | INACTIVE INGREDIENT | XRY0V4VZKZ | 1 | |
| ACETYL HEXAPEPTIDE-8 | INACTIVE INGREDIENT | L4EL31FWIL | 1 | |
| ADENOSINE | INACTIVE INGREDIENT | K72T3FS567 | 1 | |
| ALANINE | INACTIVE INGREDIENT | OF5P57N2ZX | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| AMYRIS BALSAMIFERA OIL | INACTIVE INGREDIENT | I1BJ961J2E | 1 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 1 | |
| ASPARAGINE | INACTIVE INGREDIENT | 5Z33R5TKO7 | 1 | |
| BIS-PEG-18 METHYL ETHER DIMETHYL SILANE | INACTIVE INGREDIENT | OEB4R3WW9C | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CAPRYLHYDROXAMIC ACID | INACTIVE INGREDIENT | UPY805K99W | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | INACTIVE INGREDIENT | 71DD5V995L | 1 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | 1 | |
| CLARY SAGE OIL | INACTIVE INGREDIENT | 87L0D4U3M0 | 1 | |
| CYMBOPOGON SCHOENANTHUS OIL | INACTIVE INGREDIENT | XE7K568ILO | 1 | |
| CYSTEINE | INACTIVE INGREDIENT | K848JZ4886 | 1 | |
| CYSTINE | INACTIVE INGREDIENT | 48TCX9A1VT | 1 | |
| GLUTAMINE | INACTIVE INGREDIENT | 0RH81L854J | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 1 | |
| HISTIDINE | INACTIVE INGREDIENT | 4QD397987E | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| ISOLEUCINE | INACTIVE INGREDIENT | 04Y7590D77 | 1 | |
| LAVANDULA ANGUSTIFOLIA FLOWERING TOP | INACTIVE INGREDIENT | 9YT4B71U8P | 1 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| LEUCINE | INACTIVE INGREDIENT | GMW67QNF9C | 1 | |
| LYSINE | INACTIVE INGREDIENT | K3Z4F929H6 | 1 | |
| METHIONINE | INACTIVE INGREDIENT | AE28F7PNPL | 1 | |
| MUSA BASJOO WHOLE | INACTIVE INGREDIENT | V3AYC3JL9Y | 1 | |
| NEOPENTYL GLYCOL | INACTIVE INGREDIENT | QI80HXD6S5 | 1 | |
| ORANGE | INACTIVE INGREDIENT | 5EVU04N5QU | 1 | |
| ORNITHINE | INACTIVE INGREDIENT | E524N2IXA3 | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PALMITOYL PENTAPEPTIDE-4 | INACTIVE INGREDIENT | KK181SM5JG | 1 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 1 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| PHENYLALANINE | INACTIVE INGREDIENT | 47E5O17Y3R | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| PREZATIDE COPPER | INACTIVE INGREDIENT | 6BJQ43T1I9 | 1 | |
| PROLINE | INACTIVE INGREDIENT | 9DLQ4CIU6V | 1 | |
| ROSA DAMASCENA FLOWER OIL | INACTIVE INGREDIENT | 18920M3T13 | 1 | |
| SERINE | INACTIVE INGREDIENT | 452VLY9402 | 1 | |
| SODIUM CHONDROITIN SULFATE (PORCINE; 5500 MW) | INACTIVE INGREDIENT | H5BJH23Z9A | 1 | |
| SODIUM PHOSPHATE | INACTIVE INGREDIENT | SE337SVY37 | 1 | |
| THIOREDOXIN | INACTIVE INGREDIENT | XJZ418133Z | 1 | |
| THREONINE | INACTIVE INGREDIENT | 2ZD004190S | 1 | |
| TORREYA NUCIFERA WHOLE | INACTIVE INGREDIENT | 91Z68135ZV | 1 | |
| TRYPTOPHAN | INACTIVE INGREDIENT | 8DUH1N11BX | 1 | |
| TYROSINE | INACTIVE INGREDIENT | 42HK56048U | 1 | |
| VALINE | INACTIVE INGREDIENT | HG18B9YRS7 | 1 |
Products#
Every source-derived product name is available through these pages.
- Dr. Dream Advanced Facial Treatment Serum
- WITCH HAZEL
- BIS-PEG-18 METHYL ETHER DIMETHYL SILANE
- BUTYLENE GLYCOL
- PANTHENOL
- CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)
- CAPRYLYL GLYCOL
- TORREYA NUCIFERA WHOLE
- ROSA DAMASCENA FLOWER OIL
- MUSA BASJOO WHOLE
- ACETYL HEXAPEPTIDE-8
- PALMITOYL OLIGOPEPTIDE
- PALMITOYL TETRAPEPTIDE-7
- POLYSORBATE 80
- GLYCERIN
- CAPRYLHYDROXAMIC ACID
- ADENOSINE
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- NEOPENTYL GLYCOL
- CARBOXYMETHYLCELLULOSE SODIUM
- SODIUM CHONDROITIN SULFATE (PORCINE; 5500 MW)
- LAVANDULA ANGUSTIFOLIA FLOWERING TOP
- CYMBOPOGON SCHOENANTHUS OIL
- ABIES SIBIRICA LEAF OIL
- ORANGE
- AMYRIS BALSAMIFERA OIL
- CLARY SAGE OIL
- LECITHIN, SOYBEAN
- SODIUM PHOSPHATE
- HYALURONATE SODIUM
- THIOREDOXIN
- PREZATIDE COPPER
- PALMITOYL PENTAPEPTIDE-4
- GLYCINE
- GLUTAMINE
- LYSINE
- LEUCINE
- METHIONINE
- VALINE
- SERINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53077-2001 | 53077-2001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, EXTENDED RELEASE / ORAL | 10 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION / INTRAVENOUS | 790 mg | ||
| METHIONINE | METHIONINE | AE28F7PNPL | INJECTION / INTRATHECAL | 0.01 %w/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRALESIONAL | 4 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 200 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRADERMAL | 0.2 %w/v | ||
| SERINE | SERINE | 452VLY9402 | INJECTION / INTRAVENOUS | 0.5 %w/v | ||
| CYSTEINE | CYSTEINE | K848JZ4886 | SOLUTION / INTRAVENOUS | 0.01 %w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SUSPENSION / ORAL | 1080 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED / ORAL | 24 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CREAM / TOPICAL | 20 mg | ||
| PROLINE | PROLINE | 9DLQ4CIU6V | INJECTION, SOLUTION / INTRAVENOUS | 0.34 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION/ DROPS / OPHTHALMIC | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET, ORALLY DISINTEGRATING / ORAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 5 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / INTRAVENOUS | 900 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3.76 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | GRANULE, FOR SUSPENSION / ORAL | 240 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | OINTMENT / TOPICAL | 0.15 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| HISTIDINE | HISTIDINE | 4QD397987E | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 0.16 %w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | GRANULE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 4 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 10 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRASYNOVIAL | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CONCENTRATE / INTRAVENOUS | 4680 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CREAM / VAGINAL | 0.75 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION, SOLUTION / INTRAMUSCULAR | 0.14 %w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SUSPENSION / ENTERAL | 2920 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET / ORAL | 163.31 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE, EXTENDED RELEASE / ORAL | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | 0.5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUPPOSITORY / VAGINAL | 28 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | ENEMA / RECTAL | 0.01 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6446c71b-fc50-435d-bb7d-a2c9747efa78 | ce0939de-1b69-4a4f-9641-e10794d9f17c | 2012-08-24 | Warnings | 6446c71b-fc50-435d-bb7d-a2c9747efa78 ce0939de-1b69-4a4f-9641-e10794d9f17c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
